Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H5159

Caption

Enhancing the market review process

Impact

The anticipated impact of HB 5159 on state laws is substantial, as it seeks to refine existing frameworks regarding health care resources, equity, and management services. The measure also introduces a task force dedicated to studying primary care access and payment delivery systems, which indicates a commitment to improving health care accessibility. The bill’s provisions aim to ensure that health care services are not only sustainable but are also equitably distributed across diverse populations. By incorporating measures of economic equity into health policy, the legislation addresses the systemic disparities observed in health service delivery.

Summary

House Bill 5159, also known as the Act Enhancing the Market Review Process, aims to reform the oversight of the health care market in Massachusetts. Key changes include amendments to chapters 6A and 6D of the General Laws, particularly focusing on redefining roles and responsibilities within the healthcare policy framework. This legislation sets out to enhance the review process for health care rates and expenditures, introducing stricter criteria for assessing whether payment rates are excessive. Furthermore, the bill emphasizes affordability for consumers and purchasers of health insurance products, reinforcing principles of solvency and actuarial soundness throughout the evaluation process.

Contention

Notably, discussions around HB 5159 suggest potential contention in implementation, especially regarding the role of private equity and significant investors in health care operations. There are concerns about how these market dynamics could influence the affordability and availability of health care services. Additionally, while there is general support for enhancing the market review process, some advocates warn that the focus on affordability might unintentionally impede investment in necessary health care innovations and resources. Debates around the balance between regulation and operational autonomy highlight the complexity inherent in health care reform.

Companion Bills

No companion bills found.

Similar Bills

MA S2871

Site Information & Links

MA S2881

Site Information & Links

MA H4643

Enhancing the market review process

MA H4653

Enhancing the market review process

MA H4620

Enhancing the market review process

MA S3012

Relative to pharmaceutical access, costs and transparency

MA S875

To promote transparency in prescription drug prices

MA H4910

Similar Bills